USPH stock touches 52-week low at $72.15 amid market challenges

In a challenging market environment, US Physical Therapy Inc (NYSE:USPH) stock has reached its 52-week low, trading at $72.15. According to InvestingPro data, the company maintains a "GOOD" Financial Health score, with analysts setting price targets between $98 and $113. This significant downturn reflects a broader trend for the company, which has seen a substantial 1-year change with a decline of -35.6%. Investors are closely monitoring USPH as it navigates through the headwinds that have pressured the healthcare sector, leading to this notable dip in its stock price. The company, which operates outpatient physical therapy clinics, is now at a critical juncture as it looks to strategies that could potentially revitalize its performance in the coming quarters. Despite current challenges, USPH has maintained dividend payments for 15 consecutive years and shows strong cash flows to cover interest payments. The RSI indicates the stock is in oversold territory, one of several key metrics available on InvestingPro, where investors can access 12 additional ProTips and comprehensive analysis.

In other recent news, U.S. Physical Therapy reported its fourth-quarter 2024 earnings, with an earnings per share (EPS) of $0.52, missing the expected $0.69. However, the company exceeded revenue forecasts, generating $180.45 million. The firm has been expanding its market presence, adding approximately 70 clinics and entering new states, including Wyoming and Pennsylvania. Despite these expansions, anticipated Medicare rate cuts pose potential financial challenges for the company. Analyst firm Jefferies raised concerns about the missed EPS and its implications for future earnings. Meanwhile, U.S. Physical Therapy is focusing on increasing home-based therapy services and virtual staffing, with an expected EBITDA range of $88 million to $93 million for 2025. The company’s leadership remains optimistic about overcoming industry challenges, emphasizing strategic rate negotiations and payer contract adjustments.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.